SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-21-000394
Filing Date
2021-03-26
Accepted
2021-03-26 17:07:40
Documents
2
Group Members
ORBIMED CAPITAL GP VI LLCORBIMED CAPITAL LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 ss195260_sc13da.htm SC 13D/A 120401
2 JOINT FILING AGREEMENT ss195260_ex9901.htm EX-99.1 6520
  Complete submission text file 0000947871-21-000394.txt   128653
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 275 SHORELINE DRIVE, SUITE 450 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 450 REDWOOD CITY CA 94065 650-487-2800
GRAYBUG VISION, INC. (Subject) CIK: 0001534133 (see all company filings)

IRS No.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91725 | Film No.: 21778391
SIC: 2834 Pharmaceutical Preparations